Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.32 |
| ▸ | TET3 | O43151 | 1/20 | 0.32 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4949678 | 0.76 | RNPEP (0.44) | TDP1 | |
| SCHEMBL18112573 | 0.73 | OR51E2 (0.50) | CYP2D6CYP2C19TSHROR51E2TET2 | |
| SCHEMBL4561556 | 0.73 | TP53 (0.35) | OR51E2TDP1 | |
| SCHEMBL29261752 | 0.73 | TDP1 (0.35) | TSHRALDH1A1OR51E2LMNATDP1 | |
| Cystine SCHEMBL8332360 | 0.71 | PTGS1 (0.50) | ALDH1A1 | |
| SCHEMBL5518553 | 0.71 | GABRR1 (0.46) | ENPEP | |
| Cystine SCHEMBL5018669 | 0.71 | PTGS1 (0.50) | ALDH1A1 | |
| SCHEMBL11193240 | 0.71 | GABRR1 (0.46) | ENPEP | |
| Cystine SCHEMBL21114356 | 0.71 | PTGS1 (0.50) | ALDH1A1 | |
| Cystine SCHEMBL8332353 | 0.71 | PTGS1 (0.50) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118203671-A | Nanometer medicinal composition based on charge assembly and having responsiveness, and preparation method and application thereof | 锐康九域(厦门)医药科技有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118203671-A | Nanometer medicinal composition based on charge assembly and having responsiveness, and preparation method and application thereof | 锐康九域(厦门)医药科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-5847061-A | Process for producing polymers having terminal functional group which may be protected | KURARAY CO., LTD. (JP) | 1998-12-08 | — | — | US | disclosed |
| EP-0704460-B1 | PROCESS FOR PRODUCING POLYMER TERMINATED WITH OPTIONALLY PROTECTED FUNCTIONAL GROUP | KURARAY CO (JP) | 1998-11-04 | — | — | EP | disclosed |
| EP-0704460-A1 | PROCESS FOR PRODUCING POLYMER TERMINATED WITH OPTIONALLY PROTECTED FUNCTIONAL GROUP | KURARAY CO., LTD. (JP) | 1996-04-03 | — | — | EP | disclosed |